PROTAC Her3 Degrader-1
PROTAC Her3 Degrader-1 (compound CY1) is a Her3 PROTAC degrader that recruits CRBN. PROTAC Her3 Degrader-1 is applicable to research related to breast cancer, lung cancer, head and neck cancer, and prostate cancer.
For research use only. We do not sell to patients.
- CAS No.: 2102694-52-8
- Formula: C50H57Cl2N9O13
- Molecular Weight:1062.95
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
All EGFR Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
HER3 |
Chemical Information
-
CAS No. 2102694-52-8
-
Molecular Weight 1062.95
-
Formula C50H57Cl2N9O13
-
SMILES
N#CC1=CN=C2C=C(C(OC)=CC2=C1NC3=CC(OC)=C(C=C3Cl)Cl)OCCCN4CCN(CC4)CC(NCCOCCOCCOCCNC(COC5=CC=CC(C(N6C7C(NC(CC7)=O)=O)=O)=C5C6=O)=O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
PROTAC Her3 Degrader-1 Related Classifications
HY-103629 Related Classifications
Powered by Bioz